Caligan Partners LP's Form 4 filing
Standard Biotools Inc.LAB · filed Apr 13, 2022
- Accession no.
- 0000902664-22-002542
- Filed
- Apr 13, 2022, 4:27 PM ET
- Trade date
- Apr 11-12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $741.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Caligan Partners LPCIK 0001727492 | 10% Owner |
| Johnson David EdwardCIK 0001785557 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2022 | Common Stock, $0.001 par value per share ("Common Stock") | PPurchaseAcquired | +145,000 | $3.87 | +$561,150 | 9,034,838 | Indirect | |
| Apr 12, 2022 | Common Stock | PPurchaseAcquired | +50,000 | $3.60 | +$180,000 | 9,084,838 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Remarks: The Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of his or its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.